Sign in
4

Changes in Ownership

CAPRICOR THERAPEUTICS, INC. Filed Acc 0001104659-20-022098

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 30,178 shares (grant or award)
  • CHIEF FINANCIAL OFFICER returned 30,178 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Grant or award · Stock Option (Right to Buy) +14,000 14,000 D: show line 1 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Grant or award · Stock Option (Right to Buy) +5,000 5,000 D: show line 2 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Grant or award · Stock Option (Right to Buy) +3,500 3,500 D: show line 3 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Grant or award · Stock Option (Right to Buy) +3,000 3,000 D: show line 4 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Grant or award · Stock Option (Right to Buy) +2,500 2,500 D: show line 5 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Grant or award · Stock Option (Right to Buy) +2,178 2,178 D: show line 6 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Returned to the company · Stock Option (Right to Buy) −14,000 0 D: show line 7 in the form
Bergmann Anthony CHIEF FINANCIAL OFFICER 2020-02-12 Returned to the company · Stock Option (Right to Buy) −5,000 0 D: show line 8 in the form
Loading xslF345X03/tm208086d1_4.xml…